Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005791

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 45,470 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Paolini John F. CHIEF MEDICAL OFFICER 2023-04-01 Grant or award · Share Option +38,974 38,974 D
Paolini John F. CHIEF MEDICAL OFFICER 2023-04-01 Grant or award · Restricted Share Unit +6,496 6,496 D
Loading xslF345X04/form4-04032023_040421.xml…